hypocrellin a has been researched along with gadolinium in 2 studies
| Studies (hypocrellin a) | Trials (hypocrellin a) | Recent Studies (post-2010) (hypocrellin a) | Studies (gadolinium) | Trials (gadolinium) | Recent Studies (post-2010) (gadolinium) |
|---|---|---|---|---|---|
| 172 | 0 | 72 | 13,838 | 519 | 6,282 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Z; Hu, Z; Jin, S; Liu, X; Ren, W; Tian, G; Yan, L; Yin, W; Zhang, X; Zhao, Y; Zhou, L | 1 |
| He, D; Liu, Q; Na, N; Ouyang, J; Yang, C; Zhao, Y | 1 |
2 other study(ies) available for hypocrellin a and gadolinium
| Article | Year |
|---|---|
A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Contrast Media; Fluorides; Gadolinium; HeLa Cells; Humans; Infrared Rays; Magnetic Resonance Imaging; Metal Nanoparticles; Neoplasms; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Polysorbates; Quinones; Radiography; Singlet Oxygen; Yttrium | 2013 |
Dual-modal imaging and photodynamic therapy using upconversion nanoparticles for tumor cells.
Topics: Contrast Media; Fluorides; Gadolinium; HEK293 Cells; HeLa Cells; Humans; Magnetic Resonance Imaging; Microscopy, Confocal; Nanoparticles; Neoplasms; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Quinones; Silicon Dioxide; Yttrium | 2014 |